Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Microbot Medical Inc. MBOT

Full chart Compare
Set alert

Price alert · MBOT

All alert types
1.06 USD +0.02 (+1.92%)

Nov 3, 2026, 3:40 PM EST

1.03 Day range 1.09
0.93 52-week range 2.86
YTD
-47.00%
1 year
-50.00%

Financial health

Altman Z-Score

7.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -6.9×
FY 2016: -9.0×FY 2017: -18.0×FY 2018: -2.1×FY 2019: -6.0×FY 2020: -5.3×FY 2021: -4.7×FY 2022: -1.7×FY 2023: -1.6×FY 2024: -1.5×FY 2025: -6.9×
FY 2016 5y median -1.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.2×
FY 2016: 51.4×FY 2017: 13.7×FY 2018: 11.5×FY 2019: 1.4×FY 2020: 2.0×FY 2021: 3.7×FY 2022: 3.0×FY 2023: 3.7×FY 2024: 5.0×FY 2025: 1.2×
FY 2016 5y median 3.7× FY 2025
P/FCF -7.0×
FY 2016: -108×FY 2017: -27.8×FY 2018: -2.8×FY 2019: -6.5×FY 2020: -6.7×FY 2021: -5.7×FY 2022: -1.9×FY 2023: -2.0×FY 2024: -2.0×FY 2025: -7.0×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -6.8×
FY 2016: -8.8×FY 2017: -24.0×FY 2018: -1.4×FY 2019: -2.2×FY 2020: -3.3×FY 2021: -3.6×FY 2022: -1.5×FY 2023: -1.4×FY 2024: -1.3×FY 2025: -6.8×
FY 2016 5y median -1.5× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -14.3%
FY 2016: -0.9%FY 2017: -3.6%FY 2018: -36.1%FY 2019: -15.4%FY 2020: -15.0%FY 2021: -17.7%FY 2022: -53.2%FY 2023: -51.2%FY 2024: -50.5%FY 2025: -14.3%
FY 2016 5y median -50.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -16.9%
FY 2016: -569.8%FY 2017: -76.2%FY 2018: -545.9%FY 2019: -23.0%FY 2020: -37.7%FY 2021: -78.7%FY 2022: -180.7%FY 2023: -238.6%FY 2024: -324.2%FY 2025: -16.9%
FY 2016 5y median -180.7% FY 2025
ROIC -18.8%
FY 2016: -372.7%FY 2017: -50.2%FY 2018: -544.7%FY 2019: -22.3%FY 2020: -36.2%FY 2021: -75.4%FY 2022: -171.3%FY 2023: -208.3%FY 2024: -319.3%FY 2025: -18.8%
FY 2016 5y median -171.3% FY 2025
ROA -16.1%
FY 2016: -286.9%FY 2017: -68.9%FY 2018: -119.2%FY 2019: -19.5%FY 2020: -34.9%FY 2021: -67.5%FY 2022: -138.1%FY 2023: -129.0%FY 2024: -189.7%FY 2025: -16.1%
FY 2016 5y median -129.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -100.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -26.8%
FY 2016: 73.8%FY 2017: 45.3%FY 2018: -37.5%FY 2019: 0.1%FY 2020: -25.5%FY 2021: -25.0%FY 2022: -16.9%FY 2023: 25.8%FY 2024: -18.0%FY 2025: -26.8%
FY 2016 FY 2025
EPS (diluted) 60.3%
FY 2016: -40.8%FY 2017: 91.6%FY 2018: 4.7%FY 2019: -109.9%FY 2020: 24.1%FY 2021: -23.3%FY 2022: -13.8%FY 2023: 42.0%FY 2024: 30.5%FY 2025: 60.3%
FY 2016 FY 2025
Free Cash Flow -48.1%
FY 2016: -5.7%FY 2017: -505.9%FY 2018: -12.6%FY 2019: -20.5%FY 2020: -10.1%FY 2021: -28.3%FY 2022: -23.5%FY 2023: 26.4%FY 2024: -3.3%FY 2025: -48.1%
FY 2016 FY 2025

Financial Health

Current Ratio 23.3×
FY 2016: 4.2×FY 2017: 20.7×FY 2018: 1.2×FY 2019: 7.4×FY 2020: 18.8×FY 2021: 8.0×FY 2022: 4.3×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 23.3×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 23.2×
FY 2016: 4.2×FY 2017: 20.7×FY 2018: 1.2×FY 2019: 7.4×FY 2020: 18.8×FY 2021: 8.0×FY 2022: 4.3×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 23.2×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.3×FY 2017: 2.1×FY 2018: 0.7×FY 2019: 3.9×FY 2020: 2.1×FY 2021: 1.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: -28.8×FY 2017: -22.1×FY 2018: 0.0×FY 2019: -70.3×FY 2020: -114×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31